Pfizer's R&D program has developed 4 Billion COVID-19 vaccines for +180 countries as of Oct. 2022
Register to read the full analysis —or— Upgrade to access more features
#vaccine
#COVID-19
#R&D
#drugs
Actual Direct Impact
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue
There is no comment yet.